John Huggins to Enzyme Inhibitors
This is a "connection" page, showing publications John Huggins has written about Enzyme Inhibitors.
Connection Strength
0.113
-
First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of?=50?% of Predicted Value. Lung. 2016 10; 194(5):739-43.
Score: 0.113